ERIN HILL: Open Payments
NPI 1962655043 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 77 payments from 17 companies in 2025. Trend: 2023 $1,487 · 2024 $1,945 · 2025 $1,659
Food & beverage: $1,560Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $273 |
| Corium, LLC | 14 | $244 |
| GENZYME CORPORATION | 10 | $224 |
| GlaxoSmithKline, LLC. | 9 | $206 |
| AstraZeneca Pharmaceuticals LP | 9 | $199 |
| Galderma Laboratories, L.P. | 10 | $137 |
| Kowa Pharmaceuticals America, Inc. | 3 | $81 |
| Seqirus USA Inc | 2 | $54 |
| PFIZER INC. | 1 | $37 |
| Amgen Inc. | 2 | $35 |
Products named: DUPIXENT, Azstarys, NUCALA, TEZSPIRE, NEMLUVIO, ZORYVE, FASENRA, Flucelvax.
Industry payments across LA — which companies pay providers there.
